Photo Gallery

Login

Search

News & Updation

  • WJPPS NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2017 Issue has been successfully launched on 1 November 2017

  • ICV
  • WJPPS Rank with Index Copernicus Value 52.51 due to high reputation at International Level

  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from 6.041 to 6.647 due to high quality Publication at International Level

  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  

Abstract

ANTICANCER ACTIVITY AND MOLECULAR DOCKING OF SOME SYNTHESIZED 2-THIOHYDANTOIN DERIVATIVES

Mohamed Abd El-Moneim, Elsherbiny H. Elsayed and Maha El-Ashry*

ABSTRACT

Objective: the present work is designed for synthesis of a series of novel 2- thiohydantoin derivatives, description of the electron impact (EI) ionization mass spectral fragmentation patterns and evaluation of them against human breast cancer cells (MCF-7) and human prostate cancer cells (PC-3). Methods: A series of novel 3-[(2,5-dihydroxybenzylidene)amino]-2-thiohydantoin derivatives have been synthesized. The structures of the synthesized compounds were characterized by spectroscopic methods such as IR, HNMR, 13CNMR, mass spectroscopy and elemental analysis. The anti-tumor activity of the new compounds were evaluated against human breast cancer cells (MCF-7) and human prostate cancer cells (PC-3). Molecular docking also evaluated. Results: The spectroscopic data clearly confirmed the structure of the newly synthesized compounds. The anticancer activity and molecular docking for the compounds were evaluated. Among the tested compounds 3 and 7 exhibited the highest activity. Conclusion: 2-thiohydantoin derivatives containing (2,3-dihydroxybenzylidene)amino substituent were synthesized. The synthesized compounds exhibited moderate anticancer activities. On docking study, the most favorable interaction between the synthesized compounds and the protein receptor (3hb5) were with compounds 6 and 2.

Keywords: 2-Thiohydantoin, Synthesis, Antitumor, Molecular Docking.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More